Education has become a crucial factor for personal success and development in today’s world. Every year, there is an increasing demand for high-quality, affordable training that meets the needs of the ...

This was the stock's second consecutive day of losses.

Charles River Laboratories International Inc. closed 46.74% short of its 52-week high of $264.71, which the company reached ...

FBLG READ THE FULL FBLG RESEARCH REPORT Business Update Phase 1/2 Trial in Diabetic Foot Ulcers to Initiate in 2Q25 ...

Charles River Watershed Association (CRWA) has elected Paul Levy as the president of the nonprofit’s board of directors at its annual meeting last Wednesday.

One of the most promising aspects of AI and its integration into the pharmaceutical industry is the technology’s potential to discover new molecules and potential therapies. Pfizer is partnering with ...

Corebridge Financial Inc. lowered its position in Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 5.5% during the fourth quarter, according to its most recent disclosure ...

Pfizer and Flagship Pioneering are turning to autoimmune disease as the sixth plank of their multibillion-dollar, 10-program ...

Pfizer (PFE) and Pioneering Medicines, Flagship Pioneering’s in-house drug discovery and development unit, announced an agreement to discover ...

S&P 500 and Nasdaq hit their six-month low level on Monday as investors’ concerns rise over the upcoming Donald Trump’s ...

The Dow Jones rose on the stock market today despite President Trump talking on tariffs. A Warren Buffett stock cleared an entry.

Proprietary master cell bank of fibroblast-based spheroids product candidate, CYWC628, completed in accordance with Good Manufacturing Practices after successfully passing all required safety testing ...